Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Jun-Jul;26(5-6):505-515.
doi: 10.1080/1061186X.2017.1405424. Epub 2017 Dec 1.

Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer

Affiliations
Comparative Study

Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer

Tao Wang et al. J Drug Target. 2018 Jun-Jul.

Abstract

Pancreatic cancer has been a life-threatening illness associated with high incidence and mortality rates. Paclitaxel (PCT) that causes mitotic arrest in cancer cells disrupting microtubule function is used for pancreatic cancer treatment. Nausea, anorexia and abdominal pain are some of the typical dose-limiting toxicity associated gastrointestinal side effects of the drug. Here, we present the use of polymeric mixed micelles to enable a targeted delivery of PCT and to provide additional advantages such as enhanced drug solubility, bioavailability and minimal dose-limiting toxicity. Also, these micelles self-assemble with pancreatic cancer cells-specific phage proteins P38, L1 and with the hydrophobic drug PCT resolving the issue of complex chemistry efforts normally needed for any conjugation. Our cytotoxicity and binding experiment results in vitro in 2 D and 3 D models suggested that the phage protein-targeted drug-loaded micelles bind and exhibit higher cell killing over the non-targeted ones.

Keywords: Cancer targeting; in vitro uptake and cytotoxicity studies; nanoparticles; paclitaxel; pancreatic cancer; pharmacokinetics; polymeric micelles; self-assembling; spheroid model; targeted drug delivery.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Characterization of the Micelle Formations. (A) Critical micelle concentration (CMC) determination; (B) Size; (C) Zeta potential; (D) Drug release profiles.
Figure 2.
Figure 2.
Stability testing of phage-micelles in PBS under accelerated conditions such as shaking and elevated temperature of 37°C as opposed to normal storage at 4°C.
Figure 3.
Figure 3.
Stability testing using FBS. P38 and L1 Modified micelles had slower and lesser protein adsorption / interaction in FBS within 48h at 37 °C.
Figure 4.
Figure 4.
Cellular uptake by P38 phage micelles.
Figure 5.
Figure 5.
Cellular uptake by L1 phage micelles.
Figure 6.
Figure 6.
Fluorescence microscopy study the association of micellar nanoparticle with targeted panc-1 cells, showing improved targeted cell binding of p38 and L1 phage micelles when compared to non-modified plain micelles.
Figure 7.
Figure 7.
In vitro antitumor activity. (A) Cell viability tested on monolayer panc-1 cancer cells; (B) In vitro apoptosis-inducing ability; (C) In vitro apoptosis-inducing ability

References

    1. Reynolds RB, Folloder J. Clinical Management of Pancreatic Cancer. Journal of the advanced practitioner in oncology. 2014. Sep-Oct;5(5):356–64. PubMed PMID: ; PubMed Central PMCID: PMC4457174. - PMC - PubMed
    1. Boussios S, Pentheroudakis G, Katsanos K, et al. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Annals of gastroenterology. 2012;25(2):106–118. PubMed PMID: ; PubMed Central PMCID: PMC3959393. - PMC - PubMed
    1. Lowery MA, O’Reilly EM. Pancreatic cancer: the role of molecular markers in diagnosis and management. Clinical advances in hematology & oncology : H&O. 2011. December;9(12):900–8. PubMed PMID: . - PubMed
    1. Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World journal of gastroenterology. 2014. August 28;20(32):11142–59. doi: 10.3748/wjg.v20.i32.11142. PubMed PMID: ; PubMed Central PMCID: PMC4145755. - DOI - PMC - PubMed
    1. Liu Z, Zhang F, Koh GY, et al. Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles. Anti-cancer drugs. 2015 Feb;26(2):167–79. doi: 10.1097/CAD.0000000000000173. PubMed PMID: ; PubMed Central PMCID: PMC4272611. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources